[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (2,113)

Search Parameters:
Keywords = ASL

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
25 pages, 10986 KiB  
Systematic Review
Cystic Artery Bleeding: Imaging Insights and Systematic Review of Endovascular Management
by Francesco Tiralongo, Davide Giuseppe Castiglione, Rosita Comune, Stefano Palmucci, Chandra Bortolotto, Fiore De Simone, Filomena Pezzullo, Giovanni Ferrandino, Giacomo Sica, Paolo Ricci, Mariano Scaglione, Antonio Basile and Stefania Tamburrini
Gastrointest. Disord. 2025, 7(1), 20; https://doi.org/10.3390/gidisord7010020 - 5 Mar 2025
Abstract
Background: Cystic artery bleeding (CAB) is a rare but potentially life-threatening condition. Its etiologies span iatrogenic trauma, inflammatory diseases, and trauma, often presenting variably as hemoperitoneum, upper gastrointestinal bleeding, or hemorrhagic shock. The clinical heterogeneity of CAB complicates its diagnosis, necessitating a high [...] Read more.
Background: Cystic artery bleeding (CAB) is a rare but potentially life-threatening condition. Its etiologies span iatrogenic trauma, inflammatory diseases, and trauma, often presenting variably as hemoperitoneum, upper gastrointestinal bleeding, or hemorrhagic shock. The clinical heterogeneity of CAB complicates its diagnosis, necessitating a high index of suspicion and reliance on imaging modalities, particularly computed tomography (CT), for accurate identification of bleeding sources and differentiation from other causes of abdominal pain. Methods: This pictorial essay highlights key imaging findings in CAB and pseudoaneurysms, emphasizing the role of ultrasound, CT, and digital subtraction angiography (DSA) in diagnosis and management planning. Additionally, a systematic review of transcatheter arterial embolization (TAE) is presented, consolidating data from 64 studies encompassing 90 patients. Results: The review evaluates patient demographics, etiologies, clinical presentations, and procedural outcomes, underscoring TAE’s high efficacy and safety as a first-line treatment. Conclusions: The findings reinforce the importance of early diagnosis and tailored intervention strategies to optimize outcomes in CAB management. Full article
Show Figures

Figure 1

Figure 1
<p>Illustration of the most common variations of the cystic artery. Cystic artery (CA), right hepatic artery (RHA), left hepatic artery (LHA), proper hepatic artery (PHA), common hepatic artery (CHA), gastro-duodenal artery (GDA), superior mesenteric artery (SMA), celiac trunk (CT), inferior pancreatic-duodenal artery (IPDA), right gastric artery (RGA).</p>
Full article ">Figure 2
<p>Hemodynamically stable 78-year-old male who suffered motor vehicle accident (MVA) trauma (Hb 8 g/dL, n.v. 13–18; PCR 2.04 mg/dL, n.v. 0.0–0.5; WBC 7.66 10<sup>3</sup>/mm<sup>3</sup> n.v. 4.2–10.5). He underwent a CT with IV contrast ((<b>a</b>) non-contrast, (<b>b</b>) arterial, (<b>c</b>) venous, (<b>d</b>) delayed phase) that showed hepatic contusion and a conspicuous perihepatic and pericholecystic hematoma with cystic artery laceration and active bleeding ((<b>c</b>), white arrow), detected on the anterior gallbladder profile that increases in the portal (<b>c</b>) and delayed phases (<b>d</b>) particularly evident adjacent to a subcapsular (pre-existing) cyst. The patient underwent TAE successfully with super selective embolization of the anterior branch of the cystic artery (coils and PVA particles). The hepatic contusion was treated conservatively. Postoperatively, the patient was stable.</p>
Full article ">Figure 3
<p>Hemodynamically stable 30-year-old male who suffered MVA trauma (Hb 11.9 g/dL, n.v. 13–18; PCR 0.43 mg/dL, n.v. 0.0–0.5; WBC 15.19 10<sup>3</sup>/mm<sup>3</sup> n.v. 4.2–10.5). He underwent CT with IV contrast ((<b>a</b>) non-contrast, (<b>b</b>) arterial, (<b>c</b>) venous, (<b>d</b>) delayed phase) that showed subcapsular and pericholecystic hematoma, laceration with non-active bleeding of the fourth hepatic segment and cystic artery active bleeding ((<b>b</b>), white arrow) along the anterior gallbladder profile with conspicuous increase of contrast extravasation in portal (<b>c</b>) and delayed (<b>d</b>) phases.</p>
Full article ">Figure 4
<p>Arterial phase coronal MPR CT images (<b>a</b>) and Digital Subtraction Angiography (DSA) (<b>b</b>) both showing cystic artery conspicuous bleeding. (<b>b</b>) DSA demonstrates the entity of the bleeding (black arrow). The patient underwent TAE successfully with super-selective embolization of the anterior branch of the cystic artery (coils and Gelfoam).</p>
Full article ">Figure 5
<p>82-year-old man hospitalized for pneumonia who suddenly complained of jaundice, right upper quadrant pain and sudden decline of Hb 7.1 g/dL (PRO B NP 39,473 pg/mL, n.v. &lt; 375; PCR 9.9 mg/dL, n.v. 0.0–0.5; WBC 23.78 10<sup>3</sup>/mm<sup>3</sup> n.v. 4.2–10.5). He underwent an abdominal CT with IV contrast ((<b>a</b>) non-contrast, (<b>b</b>) arterial, (<b>c</b>) venous, (<b>d</b>) delayed phase), that showed subcapsular and pericholecystic hematoma with endoluminal active bleeding originating from a cystic artery pseudoaneurysm (CAP) ((<b>b</b>), white arrow). The patient underwent TAE successfully (coils).</p>
Full article ">Figure 6
<p>Coronal CT image in arterial phase that clearly shows CAP with irregular margins (white arrow).</p>
Full article ">Figure 7
<p>58-year-old man who was hospitalized and underwent more than one ERCP for choledocholithiasis. He complained of severe right upper quadrant pain and sudden decline of Hb 7.3 g/dL (PCR 10.82 mg/dL, n.v. 0.0–0.5; WBC 18.76 10<sup>3</sup>/mm<sup>3</sup> n.v. 4.2–10.5). He underwent an abdominal CT with IV contrast (<b>a</b>) non-contrast, (<b>b</b>) arterial, (<b>c</b>) venous, (<b>d</b>) delayed phase), which showed dilated intrahepatic bile ducts and a markedly dilated common bile duct that present inhomogeneous content and air bubbles from a previous procedure and sphincterotomy. Within the common bile duct a cystic artery pseudoaneurysm was detected with active extravasation (white arrow). The patient underwent TAE successfully.</p>
Full article ">Figure 8
<p>MPR coronal (<b>a</b>) and sagittal (<b>b</b>) clearly demonstrate cystic branch pseudoaneurysm bleeding (arrow).</p>
Full article ">Figure 9
<p>74-year-old male hospitalized for hip fracture who underwent arthroplasty (Hb 8 g/dL, n.v. 13–18; PRO B NP 39,473 pg/mL, n.v. &lt; 375; PCR 5.04 mg/dL, n.v. 0.0–0.5; WBC 7.25 10<sup>3</sup>/mm<sup>3</sup> n.v. 4.2–10.5), who suddenly complained of jaundice, right upper quadrant pain and melena. He underwent an abdominal CT with IV contrast ((<b>a</b>) non-contrast, (<b>b</b>) arterial, (<b>c</b>) venous, (<b>d</b>) delayed phase), which showed a distended gallbladder with slightly hyperdense content and a rounded hyperattenuating focus (white arrow) that did not change form and was isodense to a blood pool in the venous and delayed phases. Diagnosis: CAP with no active bleeding. The patient underwent cholecystectomy and was discharged.</p>
Full article ">Figure 10
<p>80-y.o. woman with lung infection (candidiasis) with worsening of inflammatory markers. (<b>a</b>) Non-contrast axial CT imaging demonstration of perihepatic and perisplenic fluid collections, and the presence of fluid in the gallbladder bed. The gallbladder appears increased in size. (<b>b</b>) Axial CT image shows the presence of globular enhancing vascular image (yellow arrow) along the gallbladder wall in arterial phase. The globular vascular image did not change form and was isodense to a blood pool in the venous and delayed phases (<b>c</b>,<b>d</b>). Diagnosis: CAP with no active bleeding.</p>
Full article ">Figure 11
<p>PRISMA flow diagram for study selection.</p>
Full article ">
33 pages, 5015 KiB  
Review
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways
by Helal F. Hetta, Tameem Melhem, Hashim M. Aljohani, Ayman Salama, Rehab Ahmed, Hassabelrasoul Elfadil, Fawaz E. Alanazi, Yasmin N. Ramadan, Basem Battah, Michelangelo Rottura and Matthew Gavino Donadu
Pharmaceuticals 2025, 18(3), 364; https://doi.org/10.3390/ph18030364 - 4 Mar 2025
Viewed by 50
Abstract
The rising burden of fungal infections presents a significant challenge to global healthcare, particularly with increasing antifungal resistance limiting treatment efficacy. Early detection and timely intervention remain critical, yet fungal pathogens employ diverse mechanisms to evade host immunity and develop resistance, undermining existing [...] Read more.
The rising burden of fungal infections presents a significant challenge to global healthcare, particularly with increasing antifungal resistance limiting treatment efficacy. Early detection and timely intervention remain critical, yet fungal pathogens employ diverse mechanisms to evade host immunity and develop resistance, undermining existing therapeutic options. Limited antifungal options and rising resistance necessitate novel treatment strategies. This review provides a comprehensive overview of conventional antifungal agents, their mechanisms of action, and emerging resistance pathways. Furthermore, it highlights recently approved and investigational antifungal compounds while evaluating innovative approaches such as nanotechnology, drug repurposing, and immunotherapy. Addressing antifungal resistance requires a multifaceted strategy that integrates novel therapeutics, enhanced diagnostic tools, and future research efforts to develop sustainable and effective treatment solutions. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Types of fungal diseases according to CDC categorization. CDC categorizes the illnesses brought on by fungi into four groups: the most prevalent fungal illnesses, those that affect people who live in or travel to particular regions, those that affect immunocompromised people, and other illnesses and health issues brought on by fungi. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">Figure 2
<p>Mechanisms of action of antifungal drugs. They act through the disruption of the cell wall, the disruption of the cell membrane, the inhibition of protein synthesis, the inhibition of nucleic acid synthesis, the disruption of microtubules, or the inhibition of calcinurin signaling. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">Figure 3
<p>Mechanism of resistance to common antifungal medications. (<b>a</b>) Azole resistance develops as a result of point mutations or the overexpression of the <span class="html-italic">ERG11</span> gene, which encodes the enzyme lanosterol-14-demethylase. (<b>b</b>) Echinocandin resistance develops through a mutation or substitution in the <span class="html-italic">FKS-1</span> gene, which encodes the β-1,3 glucan synthase enzyme. (<b>c</b>) Polyene resistance develops as a result of the ERG mutation, which leads to decreased ergosterol biosynthesis. (<b>d</b>) Some fungi can form biofilms and acquire resistance to nearly all antifungal classes. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">Figure 4
<p>Difference between de novo synthesis and the repurposing of a drug. The repurposing drug approach overcomes high costs, long periods, and efforts to develop novel drugs. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">Figure 5
<p>Mechanism of action of AgNPs to combat fungal resistance. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">
14 pages, 1127 KiB  
Article
Influenza Vaccination of Nurses and Other Health Care Workers in Different Occupational Settings: A Classic and AI Mixed Approach for Time-to-Event Data
by Matteo Ratti, Riccardo Rescinito, Domenico Gigante, Alberto Lontano and Massimiliano Panella
Nurs. Rep. 2025, 15(3), 87; https://doi.org/10.3390/nursrep15030087 - 3 Mar 2025
Viewed by 34
Abstract
Background: Seasonal influenza currently remains a major public health concern for the community and, in particular, the health care worker (HCW). According to the World Health Organization, HCWs are among the high-risk categories for which vaccination is recommended, due to the derived absenteeism, [...] Read more.
Background: Seasonal influenza currently remains a major public health concern for the community and, in particular, the health care worker (HCW). According to the World Health Organization, HCWs are among the high-risk categories for which vaccination is recommended, due to the derived absenteeism, productivity loss, and high probability of transmitting the disease to vulnerable individuals or patients. Therefore, an HCW vaccination policy should be adopted by every health care provider. There is growing evidence that a time effect of the vaccination event is probable, which may influence vaccine effectiveness. We designed and conducted an observational study to investigate the time to anti-influenza vaccination event of different categories of HCWs belonging to different occupational settings in a tertiary hospital during three seasons in order to retrieve some insight about HCW prioritization when designing vaccination campaigns. Materials and Methods: We retrospectively analyzed the results of two HCW anti-influenza vaccination campaigns (2022 and 2023) to assess any difference regarding job typology and unit typology (critical care, surgical, medical, service). We first fitted a classic Cox proportional hazard model and then an AI random forest model to assess variable importance. We used R, RStudio, and the survex package. Results: Overall, other HCWs reported a lower vaccination rate compared to nurses (HR 0.77; 95%CI 0.62–0.97), and service unit personnel appeared to more likely be vaccinated (HR 1.42; 95%CI 1.01–1.99) compared to those belonging to the critical care units. As expected, older workers tended to be vaccinated more frequently (HR 1.70 for the (46,65] category compared to the younger one; 95%CI 1.39–2.09). The variable importance analysis showed consistent superiority of the ward typology and age category variables with respect to time. During the entire timeline, the ward typology appeared to be more important than the HCW typology. Conclusions: Our results suggest a prioritization policy based firstly on the unit typology followed by the job typology for HCW anti-influenza campaigns. Full article
27 pages, 22222 KiB  
Review
Cardiomyopathies and Arrythmias in Neuromuscular Diseases
by Giuseppe Sgarito, Calogero Volpe, Stefano Bardari, Raimondo Calvanese, Paolo China, Giosuè Mascioli, Martina Nesti, Carlo Pignalberi, Manlio Cipriani and Massimo Zecchin
Cardiogenetics 2025, 15(1), 7; https://doi.org/10.3390/cardiogenetics15010007 - 3 Mar 2025
Viewed by 205
Abstract
Neuromuscular diseases (NMDs) encompass various hereditary conditions affecting motor neurons, the neuromuscular junction, and skeletal muscles. These disorders are characterized by progressive muscle weakness and can manifest at different stages of life, from birth to adulthood. NMDs, such as Duchenne and Becker muscular [...] Read more.
Neuromuscular diseases (NMDs) encompass various hereditary conditions affecting motor neurons, the neuromuscular junction, and skeletal muscles. These disorders are characterized by progressive muscle weakness and can manifest at different stages of life, from birth to adulthood. NMDs, such as Duchenne and Becker muscular dystrophies, myotonic dystrophy, and limb–girdle muscular dystrophies, often involve cardiac complications, including cardiomyopathies and arrhythmias. Underlying genetic mutations contribute to skeletal and cardiac muscle dysfunction, particularly in the DMD, EMD, and LMNA genes. The progressive nature of muscle deterioration significantly reduces life expectancy, mainly due to respiratory and cardiac failure. The early detection of cardiac involvement through electrocardiography (ECG) and cardiac imaging is crucial for timely intervention. Pharmacological treatment focuses on managing cardiomyopathies and arrhythmias, with an emerging interest in gene therapies aimed at correcting underlying genetic defects. Heart transplantation, though historically controversial in patients with muscular dystrophies, is increasingly recognized as a viable option for individuals with advanced heart failure and moderate muscle impairment, leading to improved survival rates. Careful patient selection and management are critical to optimizing outcomes in these complex cases. Full article
(This article belongs to the Section Rare Disease-Neuromuscular Diseases)
Show Figures

Figure 1

Figure 1
<p>Cardiac involvement in DMD [<a href="#B35-cardiogenetics-15-00007" class="html-bibr">35</a>].</p>
Full article ">Figure 2
<p>(<b>A</b>) The electrocardiography (ECG) of an 11-year-old patient showing the fragmentation of the QRS complex at I, aVL, V1, and V2, and (<b>B</b>) follow-up ECG in a 14-year-old patient showing increased the prevalence of fragmented QRS (I, aVR, aVL, V1, V2, and V3). Different types of notched and fragmented QRS patterns are indicated by arrowheads (RSr’, rSr’, and rSR’) and arrows (notched R upstroke and notched S downstroke) [<a href="#B40-cardiogenetics-15-00007" class="html-bibr">40</a>].</p>
Full article ">Figure 3
<p>The distribution of ECG abnormalities in Duchenne muscular dystrophy patients.</p>
Full article ">Figure 4
<p>Contrast CMR images of patients with BMD in the following order (from left to right): two short-axis views, a 3-chamber-view, and a 4-chamber view, demonstrating the transmural pattern of LGE in the LV free wall representing myocardial damage (white arrows). In addition, this patient presented with ECG changes typically seen in muscular dystrophy (R/S ratio ≥ 1.0 in lead V1, a deep Q-wave in leads I, II, aVL, and V5-V6, or complete right bundle branch block) [<a href="#B41-cardiogenetics-15-00007" class="html-bibr">41</a>].</p>
Full article ">Figure 5
<p>(<b>A</b>) Atrial fibrillation with slow ventricular response in a patient with Emery–Dreifuss muscular dystrophy. (<b>B</b>) Atrial fibrillation with complete heart block in a patient with Emery–Dreifuss muscular dystrophy [<a href="#B24-cardiogenetics-15-00007" class="html-bibr">24</a>].</p>
Full article ">Figure 6
<p>A typical example of a 26−year−old female Friedreich’s ataxia patient with severe cardiomyopathy. <b>Left upper</b>: T−wave inversion observed on resting electrocardiography. <b>Right upper</b>: patchy late enhancement-positive regions in the left ventricle (LV), assessed by cardiac magnetic resonance imaging. <b>Left lower</b>: retrospective M-mode echocardiography showing LV hypertrophy with an end-diastolic wall thickness of 13 mm (ejection fraction = 66%). <b>Right lower</b>: M-mode echocardiography after 5 years of follow-up, showing a decrease in end-diastolic wall thickness to 10 mm (ejection fraction = 60%). In addition, hsTNT was elevated (16.5 ng/mL) in this patient [<a href="#B92-cardiogenetics-15-00007" class="html-bibr">92</a>].</p>
Full article ">
20 pages, 2560 KiB  
Article
Grazing Intensity Accelerates Surface Soil C and N Cycling in Alpine Pastures as Revealed by Soil Genes and δ15N Ratio
by Salvatore Raniolo, Luca Da Ros, Laura Maretto, Damiano Gianelle, Federica Camin, Luana Bontempo, Piergiorgio Stevanato, Enrico Sturaro, Andrea Squartini and Mirco Rodeghiero
Sustainability 2025, 17(5), 2165; https://doi.org/10.3390/su17052165 - 3 Mar 2025
Viewed by 141
Abstract
European grasslands are vital carbon (C) sinks, contributing to climate change mitigation. Grazing intensity significantly influences soil C and nitrogen (N) cycles through effects on soil conditions and microbial communities. While heavy grazing is linked to soil C loss and altered N processes, [...] Read more.
European grasslands are vital carbon (C) sinks, contributing to climate change mitigation. Grazing intensity significantly influences soil C and nitrogen (N) cycles through effects on soil conditions and microbial communities. While heavy grazing is linked to soil C loss and altered N processes, existing studies show conflicting outcomes. This study examines the impact of cattle grazing on soil C and N cycles in a historical alpine pasture in the eastern Italian Alps (1868 m a.s.l.). The following three grazing intensities were analyzed: heavy (8.19 LU ha−1), moderate (0.59 LU ha−1), and light (0.06 LU ha−1). Soil was sampled from two depth layers (0–5 cm, 5–10 cm) and analyzed for bulk density, C and N content, C/N ratio, exchangeable N, δ15N, and microbial genes targeting general abundance (16S), N fixation (nifH), nitrification (amoA), and denitrification (nirK, nosZ) using real-time PCR. The results revealed decreased C and N concentrations with increasing grazing intensity, exclusively in the 0–5 cm soil layer. Higher δ15N and enhanced nitrification and denitrification suggest a more open N cycle under heavy grazing. These findings highlight the potential of microbial gene markers and δ15N isotopic ratios to monitor N cycle dynamics in alpine pastures, informing sustainable grazing management. Full article
Show Figures

Figure 1

Figure 1
<p>Location of the study area in the north-eastern Italian Alps (<b>left panel</b>) and a map of pasture as a function of grazing intensity (<b>right panel</b>). Different shades of blue indicate the level of grazing intensity according to the position density of the animals in a square area of 625 m<sup>2</sup>, determined with GPS collars (from July to September in the years 2019 and 2020). The soil sampling plots (diamonds) are also reported for the three grazing intensities (H—heavy, M—moderate, L—light).</p>
Full article ">Figure 2
<p>Soil bulk density mean values (g cm<sup>−3</sup>) in relation to soil depth (panel (<b>A</b>); S = superficial layer; D = deep layer) and grazing intensity (panel (<b>B</b>); H = heavy; M = moderate; L = light) in 2018. Soil mean content of NH<sub>4</sub><sup>+</sup> (mg NH<sub>4</sub><sup>+</sup> kg<sup>−1</sup>) as a function of soil depth (panel (<b>C</b>)) and soil mean content of NO<sub>3</sub><sup>−</sup> (mg NO<sub>3</sub><sup>−</sup> kg<sup>−1</sup>) in a function of the 2-way interaction of grazing intensity and soil depth (panel (<b>D</b>)) in 2018. Means not sharing any letter are significantly different by ANOVA based on the permutation test (“aovp” R function) at the specified level of significance. For details, see <a href="#app1-sustainability-17-02165" class="html-app">Table S1</a>.</p>
Full article ">Figure 3
<p>Mean values of total soil N (%) (panel (<b>A</b>)), C (%) (panel (<b>B</b>)), C/N ratio (panel (<b>C</b>)), and δ<sup>15</sup>N (panel (<b>D</b>)) as a function of the 2-way interactions between grazing intensity and soil depth (grazing intensity: H = high; M = moderate; L = low; soil depth: S = superficial layer; D = deep layer) in 2018 and 2020. Means not sharing any letter are significantly different by ANOVA based on the permutation test (“aovp” R function) at the specified level of significance. For details, see <a href="#app1-sustainability-17-02165" class="html-app">Table S2</a>.</p>
Full article ">Figure 4
<p>Correlation plot with Kendall rank’s coefficient between copies of selected genes (16S, <span class="html-italic">nifH</span>, <span class="html-italic">nosZ</span>, <span class="html-italic">nirK</span>, ratio <span class="html-italic">nosZ</span>/<span class="html-italic">nirK</span>, and <span class="html-italic">amoA</span>) and pedological variables. The copies of genes were expressed on a logarithmic scale. The level of statistical significance is marked with asterisks (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 5
<p>Boxplots showing log mean abundance of the number of copies per gram of soil dry weight for the following genes: 16S (panel (<b>A</b>)), <span class="html-italic">nifH</span> (panel (<b>B</b>)), <span class="html-italic">nirK</span> (panel (<b>C</b>)), <span class="html-italic">nosZ</span> (panel (<b>D</b>)), <span class="html-italic">nosZ</span>/<span class="html-italic">nirK</span> (panel (<b>E</b>)), and <span class="html-italic">amoA</span> (sum of AOA and AOB, panel (<b>F</b>)) in relation to grazing intensity (H = heavy grazing; M = moderate grazing; L = light grazing). Means not sharing any letter are significantly different by the ANOVA based on the permutation test (“aovp” R function) at the specified level of significance. For details, see <a href="#app1-sustainability-17-02165" class="html-app">Table S4</a>.</p>
Full article ">Figure 6
<p>Effects of grazing intensity (H = heavy grazing; M = moderate grazing; L = light grazing) on AOB presence (panel (<b>A</b>)) and ratio AOB/<span class="html-italic">amoA</span> (panel (<b>B</b>)). Means sharing the same letter are not significantly different for <span class="html-italic">p</span> &lt; 0.05 by the general linear model based on binomial distribution (panel (<b>A</b>)) and general additive model based on beta distribution (panel (<b>B</b>)) at the specified level of significance. For details, see <a href="#app1-sustainability-17-02165" class="html-app">Table S5</a>.</p>
Full article ">
26 pages, 3361 KiB  
Article
Dimensional Attachment in Romantic Relationships: Its Cognitive–Evolutionary Definition and Possible Research Implications
by Marcantonio Gagliardi and Pierpaolo Congia
Psychol. Int. 2025, 7(1), 19; https://doi.org/10.3390/psycholint7010019 - 2 Mar 2025
Viewed by 229
Abstract
Background. Attachment between romantic partners has been investigated primarily through self-reports assessing the two dimensions of avoidance and ambivalence/anxiety, typically formulating items according to observable psychological properties. However, this approach produces correlated dimensions, with a limited distinction between their features. In this work, [...] Read more.
Background. Attachment between romantic partners has been investigated primarily through self-reports assessing the two dimensions of avoidance and ambivalence/anxiety, typically formulating items according to observable psychological properties. However, this approach produces correlated dimensions, with a limited distinction between their features. In this work, we hypothesize that a definition of avoidance and ambivalence driven by their theorized cognitive–evolutionary functions can lead to a clearer-cut distinction between the two (i.e., lower correlation), still maintaining or even further highlighting the expected avoidant and ambivalent characteristics. Methods. To test our hypothesis, we administered to an adult population a battery of self-reports measuring attachment and related properties—i.e., psychological well-being, couple satisfaction, and emotion regulation. We assessed attachment through two classical attachment self-reports—the Experiences in Close Relationships-Revised (ECR-R) and Revised Adult Attachment Scale (RAAS)—and the novel, theory-informed Attachment–Caregiving Questionnaire (ACQ), building a Partial Least Squares Structural Equation Model (PLS-SEM) connecting attachment with the other constructs. Results. Our results demonstrate that measuring attachment through the ECR-R/RAAS and the ACQ leads to similar properties but a more evident characterization of avoidance and ambivalence supported by the ACQ. Conclusions. These first findings suggest that the cognitive–evolutionary definition of these two dimensions may be advantageous and should be further investigated. Full article
Show Figures

Figure 1

Figure 1
<p>PLS-SEM for Av and Am measured by the ECR-R. In the graph, to simplify visualization, each circle representing a latent variable is labeled with the corresponding indicator: (1) ECRR_Av: Avoidance from the ECR-R. (2) ECRR_Am: Ambivalence from the ECR-R. (3) PWB: Psychological well-being from the Ryff Scale. (4) ERQ_CR: Cognitive reappraisal from the EQR. (5) ERQ_ES: Expressive suppression from the EQR. (6) CSI: Satisfaction in the relationship from the CSI. * <span class="html-italic">p</span> &lt; 0.05. ** <span class="html-italic">p</span> &lt; 0.01. *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>PLS-SEM for Av and Am measured by the RAAS. In the graph, to simplify visualization, each circle representing a latent variable is labeled with the corresponding indicator: (1) RAAS_Av: Avoidance from the RAAS. (2) RAAS_Am: Ambivalence from the RAAS. (3) PWB: Psychological well-being from the Ryff Scale. (4) ERQ_CR: Cognitive reappraisal from the EQR. (5) ERQ_ES: Expressive suppression from the EQR. (6) CSI: Satisfaction in the relationship from the CSI. * <span class="html-italic">p</span> &lt; 0.05. ** <span class="html-italic">p</span> &lt; 0.01. *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 3
<p>PLS-SEM for Av and Am measured by the ACQ. In the graph, to simplify visualization, each circle representing a latent variable is labeled with the corresponding indicator: (1) ACQ_Av: Avoidance from the ACQ. (2) ACQ_Am: Ambivalence from the ACQ. (3) PWB: Psychological well-being from the Ryff Scale. (4) ERQ_CR: Cognitive reappraisal from the EQR. (5) ERQ_ES: Expressive suppression from the EQR. (6) CSI: Satisfaction in the relationship from the CSI. * <span class="html-italic">p</span> &lt; 0.05. ** <span class="html-italic">p</span> &lt; 0.01. *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 4
<p>Summary PLS-SEM for the ACQ, ECR-R, and RAAS. In the graph, (A) ACQ measures are in green. (B) ECR-R measures are in red. (C) RAAS measures are in blue. (D) Underlined values are statistically significant (<span class="html-italic">p</span> &lt; 0.001(1), <span class="html-italic">p</span> &lt; 0.01, or <span class="html-italic">p</span> &lt; 0.05). The variables are (1) Av: Avoidance (from ACQ/ECR/RAAS). (2) Am: Ambivalence (from ACQ/ECR/RAAS). (3) PWB: Psychological well-being from the Ryff Scale. (4) ERQ_CR: Cognitive reappraisal from the EQR. (5) ERQ_ES: Expressive suppression from the EQR. (6) CSI: Satisfaction in the relationship from the CSI.</p>
Full article ">
13 pages, 1913 KiB  
Article
Green Veterinary Pharmacology Applied to Beekeeping: Semi-Field and Field Tests Against Varroa destructor, Using Essential Oil of Bergamot (Citrus bergamia) and Lemon (Citrus limon)
by Roberto Bava, Ernesto Palma, Rosa Maria Bulotta, Stefano Ruga, Giovanna Liguori, Renato Lombardi, Carmine Lupia, Mariangela Marrelli, Giancarlo Statti, Vincenzo Musella, Domenico Britti and Fabio Castagna
Vet. Sci. 2025, 12(3), 224; https://doi.org/10.3390/vetsci12030224 - 2 Mar 2025
Viewed by 217
Abstract
Varroa destructor is an ectoparasitic mite that causes a true syndrome with complex symptoms in honeybees. For mite control, several synthetic active principles are commercially available. However, these formulations are proving less effective due to the acquisition of resistance mechanisms by the parasite. [...] Read more.
Varroa destructor is an ectoparasitic mite that causes a true syndrome with complex symptoms in honeybees. For mite control, several synthetic active principles are commercially available. However, these formulations are proving less effective due to the acquisition of resistance mechanisms by the parasite. Naturally derived compounds, such as essential oils, are less prone to generating resistance mechanisms in mite populations and have been proven effective in numerous independent laboratory investigations. In this study, semi-field and field tests were conducted to evaluate the acaricidal efficacy of two essential oils (Citrus bergamia and Citrus limon), which, in our previous residual contact toxicity tests, showed efficacy against Varroa mites. For semi-field cage tests, two-level cages were set up. Filter paper soaked with different concentrations of essential oils was placed in the lower compartment of the cage; 20 honeybees and 10 Varroa mites were allocated in the upper level. Mite detachment from the honeybees was evaluated after 24 and 48 h. For field tests, cardboard strips soaked with solutions of essential oils at different concentrations were inserted in the experimental hives. Weekly, the strips were replaced, and the fall of parasites on the diagnostic bottom board was assessed. Semi-field tests showed that the essential oils, at the concentrations used, were not toxic to bees. In the semi-field tests, an average acaricidal efficacy of 33% and 60% was obtained, at the highest concentration used, for bergamot and lemon essential oils, respectively. During the 4 weeks of exposure to 600 mL of BEO, the average mite mortality was 28.5%. In the experimental group treated with the intermediate concentration of 1200 mL, the average mite mortality at the end of four weeks was 30.2%, while with the highest concentration of 1800 mL, it was 40.3%. During the four weeks of exposure to 600 mL of LEO, the average mite mortality was 34.1%. In the experimental group treated with the 1200 mL concentration, the average mite mortality at the end of the four weeks was 46.6%, while with the highest concentration, it was 50.7%. This study shows that the acaricidal efficacy observed in field tests differs from that in laboratory tests. Innovative formulations are needed that allow the time-controlled and gradual release of essential oil in the field. Full article
(This article belongs to the Section Veterinary Physiology, Pharmacology, and Toxicology)
Show Figures

Figure 1

Figure 1
<p>Effects of BEO on neutralization of mites. * <span class="html-italic">p</span> &lt; 0.05 vs. BEO (10 mg/mL) after 24 h; # <span class="html-italic">p</span> &lt; 0.05 vs. BEO (10 mg/mL) after 48 h; ^ <span class="html-italic">p</span> &lt; 0.05 vs. BEO (30 mg/mL) after 24 h.</p>
Full article ">Figure 2
<p>Effects of LEO on neutralization of mites. * <span class="html-italic">p</span> &lt; 0.05 vs. LEO (10 mg/mL) after 24 h; # <span class="html-italic">p</span> &lt; 0.05 vs. LEO (10 mg/mL) after 48 h; ^ <span class="html-italic">p</span> &lt; 0.05 vs. LEO (20 mg/mL) after 24 h; ° <span class="html-italic">p</span> &lt; 0.05 vs. LEO (20 mg/mL) after 48 h; <span>$</span> <span class="html-italic">p</span> &lt; 0.05 vs. LEO (30 mg/mL) after 24 h.</p>
Full article ">Figure 3
<p>Comparison of effectiveness between BEO and LEO. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>(<b>A</b>) BEO and (<b>B</b>) LEO mortality rate; (<b>C</b>) mortality comparison for BEO and LEO essential oils.</p>
Full article ">Figure 5
<p>Comparison of effectiveness between BEO and LEO.</p>
Full article ">
17 pages, 690 KiB  
Article
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics
by Clelia Madeddu, Eleonora Lai, Manuela Neri, Elisabetta Sanna, Giulia Gramignano, Sonia Nemolato, Mario Scartozzi, Sabrina Giglio and Antonio Macciò
Int. J. Mol. Sci. 2025, 26(5), 2232; https://doi.org/10.3390/ijms26052232 - 1 Mar 2025
Viewed by 255
Abstract
The integrity of p53 machinery is crucial for platinum activity, while p53 mutation is frequent in high-grade serous ovarian cancer (HGS-OC). This study aimed to evaluate the link between p53 mutations, platinum sensitivity (PS), and the platinum-free interval (PFI) in patients with HGS-OC. [...] Read more.
The integrity of p53 machinery is crucial for platinum activity, while p53 mutation is frequent in high-grade serous ovarian cancer (HGS-OC). This study aimed to evaluate the link between p53 mutations, platinum sensitivity (PS), and the platinum-free interval (PFI) in patients with HGS-OC. We prospectively analyzed 159 consecutive women with ovarian cancer who underwent surgery. The somatic mutational status of BRCA, HRD, and TP53 (according to structural, hotspot, and functional classification) was evaluated. Among enrolled patients, 82.4% of cases were TP53-mutated (MT), and 27.8% were BRCA-MT. The distribution of TP53 mutation categories did not differ significantly between the BRCA-MT and wild-type (WT) cases. In the entire population, the proportion of PS patients was significantly lower in TP53-MT compared to TP53-WT (p = 0.0208), in nonsense/frameshift/splicing compared to missense (p = 0.0319), and in loss-of-function (LOF) compared to GOF (p = 0.0048) MT cases. For the BRCA-MT patients, structural and functional TP53 mutations were not significantly different between the PS and PR patients. Conversely, for the BRCA WT patients, the distribution of structural and functional TP53 mutations significantly differed between PS and PR patients. In a multivariate regression analysis, LOF mutations were found to be independent negative predictors of PS (HR: 0.1717; 95% CI: 0.0661–0.4461; p-value: 0.0003). Kaplan–Meier curves showed a significantly lower PFI in cases with LOF mutations in the overall population (log-rank p = 0.0020) and in BRCA-WT patients (log-rank p = 0.0140). Via multivariate COX testing, it was found that LOF mutations were independently associated with a decreased PFI (p = 0.0036). In conclusion, our data show that HGS-OC harboring p53 LOF mutations is the poorest prognostic subgroup regarding PS and the PFI. Further studies are needed to confirm our findings. Full article
(This article belongs to the Special Issue Recent Advances in Anti-Cancer Drugs)
Show Figures

Figure 1

Figure 1
<p>Platinum-free interval comparison according to BRCA and TP53 mutational status in overall population: (<b>A</b>) BRCA mutational status, (<b>B</b>) TP53 mutational status (WT = wild-type, MT = mutated), (<b>C</b>) functional classification (LOF = loss of function, GOF, gain of function), (<b>D</b>) structural mutation class, (<b>E</b>) hotspot classification.</p>
Full article ">
38 pages, 1164 KiB  
Review
A Comprehensive Review of Transformer Winding Diagnostics: Integrating Frequency Response Analysis with Machine Learning Approaches
by Meysam Beheshti Asl, Issouf Fofana, Fethi Meghnefi, Youssouf Brahami and Joao Pedro Da Costa Souza
Energies 2025, 18(5), 1209; https://doi.org/10.3390/en18051209 - 1 Mar 2025
Viewed by 159
Abstract
Frequency Response Analysis (FRA) is a proven method for detecting mechanical faults in transformers, such as winding deformations and short circuits. However, traditional FRA interpretation relies heavily on visual and subjective comparison of frequency response curves, which can introduce human bias and lead [...] Read more.
Frequency Response Analysis (FRA) is a proven method for detecting mechanical faults in transformers, such as winding deformations and short circuits. However, traditional FRA interpretation relies heavily on visual and subjective comparison of frequency response curves, which can introduce human bias and lead to inconsistent results. Integrating Machine Learning (ML) with FRA can significantly enhance fault diagnosis by automatically identifying complex patterns within the data that are difficult to detect using through human analysis. This integration can automate diagnostics, enhance accuracy, improve predictive maintenance, reduce reliance on expert interpretation and curtail operational costs. This paper reviews the application of FRA and ML alongside complementary techniques for transformer winding health assessment. Full article
(This article belongs to the Special Issue Energy, Electrical and Power Engineering: 3rd Edition)
Show Figures

Figure 1

Figure 1
<p>Timeline of events in the development of FRA.</p>
Full article ">Figure 2
<p>FRA measurement configurations: (<b>a</b>) End-to-End Open-Circuit, (<b>b</b>) End-to-End Short-Circuit, (<b>c</b>) Capacitive Inter-Winding, (<b>d</b>) Inductive Inter-Winding.</p>
Full article ">Figure 3
<p>Data preprocessing and feature extraction process from FRA results.</p>
Full article ">
14 pages, 502 KiB  
Review
Negative Hyperselection in Metastatic Colorectal Cancer for First-Line Anti-EGFR Therapy: A Narrative Review
by Giuliana Ciappina, Enrica Toscano, Alessandro Ottaiano, Maurizio Capuozzo, Pierluigi Consolo, Enrica Maiorana, Patrizia Carroccio, Tindara Franchina, Antonio Ieni, Annabella Di Mauro and Massimiliano Berretta
Int. J. Mol. Sci. 2025, 26(5), 2216; https://doi.org/10.3390/ijms26052216 - 28 Feb 2025
Viewed by 195
Abstract
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with metastatic disease posing significant therapeutic challenges. While anti-EGFR therapy has improved outcomes for patients with RAS and BRAF wild-type tumors, resistance remains a major hurdle, limiting treatment efficacy. The concept of negative [...] Read more.
Colorectal cancer (CRC) remains a leading cause of cancer-related mortality, with metastatic disease posing significant therapeutic challenges. While anti-EGFR therapy has improved outcomes for patients with RAS and BRAF wild-type tumors, resistance remains a major hurdle, limiting treatment efficacy. The concept of negative hyperselection has emerged as a refinement of molecular profiling, identifying additional genomic alterations—such as HER2 and MET amplificationsand MAP2K1 mutations—that predict resistance to anti-EGFR agents. Studies incorporating these expanded assessments have demonstrated that nearly half of patients with RAS/BRAF wild-type tumors harbor alternative resistance biomarkers, underscoring the need for expanded selection criteria. Liquid biopsies, particularly circulating tumor DNA (ctDNA) analysis, have revolutionized precision oncology by providing a minimally invasive, real-time assessment of tumor dynamics. ctDNA-based hyperselection enables the detection of resistance-associated alterations, guiding treatment decisions with greater accuracy than conventional tissue biopsies. Recent trials support the predictive value of ctDNA-defined negative hyperselection, revealing superior outcomes for patients stratified through liquid biopsy. This narrative review explores the evolving role of molecular hyperselection in first-line anti-EGFR therapy, emphasizing the integration of ctDNA to refine patient selection, enhance therapeutic efficacy, and pave the way for personalized treatment strategies in metastatic CRC. Full article
Show Figures

Figure 1

Figure 1
<p>The EGFR pathway exhibits significant redundancy, as many intracellular effectors, including PIK3CA, are shared among multiple receptor tyrosine kinases (RTKs) such as MET, HER2, ROS1, ALK, RET, and NTRK. This functional overlap implies that even in the absence of activating RAS mutations, overexpression or hyperactivation of one of these receptors can sustain pathway activation despite EGFR blockades with monoclonal antibodies (e.g., cetuximab, panitumumab). Consequently, targeting EGFR alone may be insufficient to fully suppress downstream signaling, highlighting the compensatory potential of alternative RTK activation.</p>
Full article ">
11 pages, 2314 KiB  
Case Report
Cryfibrinogen-Associated Glomerulonephritis and Monoclonal Gammopathy of Renal Significance—Case Report and Literature Review
by Edoardo Terzolo, Laura Solfietti, Michela Ferro, Antonella Barreca, Massimo Milan, Roberta Fenoglio, Savino Sciascia and Dario Roccatello
J. Clin. Med. 2025, 14(5), 1656; https://doi.org/10.3390/jcm14051656 - 28 Feb 2025
Viewed by 122
Abstract
Background/Objectives: Cryofibrinogenemia, characterized by plasma cryoprecipitation of fibrinogen and related proteins, is a rare and often under-recognized entity that can present with significant renal involvement. Methods: we describe a 66-year-old woman with progressive renal failure due to membranoproliferative glomerulonephritis driven by [...] Read more.
Background/Objectives: Cryofibrinogenemia, characterized by plasma cryoprecipitation of fibrinogen and related proteins, is a rare and often under-recognized entity that can present with significant renal involvement. Methods: we describe a 66-year-old woman with progressive renal failure due to membranoproliferative glomerulonephritis driven by cryofibrinogen deposits. Her clinical course was marked by relapsing–remitting disease with limited response to high-dose corticosteroids but significant improvement following plasma exchange. Over seven years, she underwent three kidney biopsies, revealing progressive histopathological changes, including glomerular cryofibrinogen deposits and evolving chronicity. A detailed review of the literature identified 50 cases of cryofibrinogenemia, highlighting its association with monoclonal gammopathies, malignancies, and autoimmune diseases. Results: our case uniquely underscores the pathogenic interplay between cryofibrinogenemia and a monoclonal IgG-kappa paraprotein, which was found to directly stabilize fibrinogen and drive cryoprecipitation. This novel observation aligns cryofibrinogenemia with monoclonal gammopathy of renal significance, expanding the diagnostic and therapeutic landscape for this entity. Conclusions: this report also highlights the pivotal role of kidney biopsy with electron microscopy in diagnosing cryofibrinogen-associated renal disease, particularly when conventional biomarkers are insufficient. Moreover, our findings emphasize the therapeutic utility of plasmapheresis and the potential need for therapies aimed at eliminating the pathogenetic monoclonal antibody in managing refractory cases. Enhanced awareness and further research into this rare entity are essential for advancing patient care and outcomes. Full article
(This article belongs to the Section Nephrology & Urology)
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) Glomerulus exhibiting membrano-proliferative pattern of injury in AFOG coloration; (<b>B</b>) immunofluorescence for C3; (<b>C</b>) immunofluorescence for fibrinogen; (<b>D</b>) subendothelial deposits with a structured appearance, the formation of microtubules, and annular structures; (<b>E</b>) microtubules with central bore and annular structures at higher magnification.</p>
Full article ">Figure 1 Cont.
<p>(<b>A</b>) Glomerulus exhibiting membrano-proliferative pattern of injury in AFOG coloration; (<b>B</b>) immunofluorescence for C3; (<b>C</b>) immunofluorescence for fibrinogen; (<b>D</b>) subendothelial deposits with a structured appearance, the formation of microtubules, and annular structures; (<b>E</b>) microtubules with central bore and annular structures at higher magnification.</p>
Full article ">Figure 2
<p>(<b>A</b>) HE staining: glomerular sclerosis and interstitial fibrosis increased; (<b>B</b>) trichrome staining showing glomerular sclerosis and interstitial fibrosis increasing; (<b>C</b>) immunofluorescence for C3 (+); (<b>D</b>) ultrastructural examination of a deposit; (<b>E</b>) immunofluorescence for fibrinogen (+).</p>
Full article ">Figure 2 Cont.
<p>(<b>A</b>) HE staining: glomerular sclerosis and interstitial fibrosis increased; (<b>B</b>) trichrome staining showing glomerular sclerosis and interstitial fibrosis increasing; (<b>C</b>) immunofluorescence for C3 (+); (<b>D</b>) ultrastructural examination of a deposit; (<b>E</b>) immunofluorescence for fibrinogen (+).</p>
Full article ">Figure 3
<p>Search strategy.</p>
Full article ">
17 pages, 710 KiB  
Review
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence
by Alfredo Mauriello, Adriana Correra, Anna Chiara Maratea, Alfredo Caturano, Biagio Liccardo, Marco Alfonso Perrone, Antonio Giordano, Gerardo Nigro, Antonello D’Andrea and Vincenzo Russo
J. Clin. Med. 2025, 14(5), 1652; https://doi.org/10.3390/jcm14051652 - 28 Feb 2025
Viewed by 259
Abstract
Dyslipidemia is a metabolic disorder characterized by quantitative and/or qualitative abnormalities in serum lipid levels. Elevated serum cholesterol levels can modify the turnover and recruitment of ionic channels in myocytes and cellular homeostasis, including those of inflammatory cells. Experimental and clinical data indicate [...] Read more.
Dyslipidemia is a metabolic disorder characterized by quantitative and/or qualitative abnormalities in serum lipid levels. Elevated serum cholesterol levels can modify the turnover and recruitment of ionic channels in myocytes and cellular homeostasis, including those of inflammatory cells. Experimental and clinical data indicate that inflammation is implicated in the pathophysiology of atrial remodeling, which is the substrate of atrial fibrillation (AF). Data about the association between increased lipid serum levels and AF are few and contrasting. Lipoprotein (a), adiposity, and inflammation seem to be the main drivers of AF; in contrast, low-density lipoproteins, high-density lipoproteins and triglycerides are not directly involved in AF onset. The present review aimed to describe the pathophysiological link between dyslipidemia and AF, the efficacy of lipid-lowering therapies in atherosclerotic cardiovascular disease (ASCVD) patients with and without AF, and the impact of lipid-lowering therapies on AF incidence. Full article
(This article belongs to the Special Issue Clinical Updates in Cardiac Electrophysiology: 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Mechanistic pathways linking dyslipidemia, epicardial fat, and atrial fibrillation. Dyslipidemia leads to intracellular lipid accumulation and inflammation through elevated TNF-α and IL-6 levels, promoting atrial electrical remodeling. Epicardial fat contributes to oxidative stress, increased ROS, and fibrosis via activin A, matrix metalloproteinases, and aromatase-mediated estrogen production. Fibrosis and oxidative stress result in atrial structural remodeling, neuromodulation, and eventual atrial fibrillation. AF: atrial fibrillation; IL-6: interleukin-6; ROS: reactive oxygen species; TNF-a: tumor necrosis factor-alpha.</p>
Full article ">
12 pages, 1379 KiB  
Article
Defining and Evaluating the Impact of Bleeding Severity on Time to Endoscopy and Mortality Risk: A Prospective Multicenter Cohort Study
by Clelia Marmo, Cristina Bucci, Marco Soncini, Maria Elena Riccioni, Riccardo Marmo and on behalf of the GISED Study Group
J. Clin. Med. 2025, 14(5), 1643; https://doi.org/10.3390/jcm14051643 - 28 Feb 2025
Viewed by 165
Abstract
Background: Upper gastrointestinal bleeding severity (BleSev) is commonly defined by evaluating different factors that are frequently interdependent on each other, expressing the same underlying cause. Aim: This study aimed to define the severity of a bleeding event and verify its impact on death [...] Read more.
Background: Upper gastrointestinal bleeding severity (BleSev) is commonly defined by evaluating different factors that are frequently interdependent on each other, expressing the same underlying cause. Aim: This study aimed to define the severity of a bleeding event and verify its impact on death risk and the time to endoscopy. Methods: We analyzed 12 factors (demographic, hemodynamic, biochemical, and clinical) that could be associated with BleSev. We identified the independent weight of each factor in predicting a composite endpoint (need for surgery, interventional radiology, and death) and the effect of the interactions between time to endoscopy and BleSev on death risk. Results: Clinical data of 2.525 patients were included. Of the 12 factors, 5 were retained in the final model as follows: altered mental status, systolic blood pressure ≤ 100 mmHg, blood urea nitrogen level ≥ 130 mg/dL, hematemesis, and hemoglobin level ≤ 8 g/dL (AUC performance curve, 0.79). We identified the following three classes of BleSev: low (0–1 points, 2.4%), intermediate (3–4 points, 8.6%), and high (≥5 points, 21.1%). When no factors were present, the death risk was 1%; when all factors were present, the risk was 45.5%. Notably, the death risk increased with BleSev but was generally independent of time to endoscopy. However, in high-risk cases, early endoscopy (within 6–12 h) was associated with a reduced mortality rate. Conclusions: This study defines a risk model for BleSev and highlights the need for targeted endoscopic timing strategies based on BleSev for optimizing survival rates. Patients in the highest risk category may benefit from more urgent endoscopic interventions. Full article
(This article belongs to the Section Gastroenterology & Hepatopancreatobiliary Medicine)
Show Figures

Figure 1

Figure 1
<p>Effects of interactions between time to endoscopy and BleSev on death risk by time to endoscopy.</p>
Full article ">Figure 2
<p>Effects of interactions between time to endoscopy and BleSev on death risk by BleSev scale.</p>
Full article ">
14 pages, 693 KiB  
Article
Multimodal Morphometric Similarity Network Analysis of Autism Spectrum Disorder
by Antonio Del Casale, Darvin Shehu, Maria Camilla Rossi-Espagnet, Clarissa Zocchi, Irene Bilotta, Jan Francesco Arena, Alessandro Alcibiade, Barbara Adriani, Daniela Longo, Carlo Gandolfo, Andrea Romano, Stefano Ferracuti, Alessandro Bozzao and Antonio Napolitano
Brain Sci. 2025, 15(3), 247; https://doi.org/10.3390/brainsci15030247 - 26 Feb 2025
Viewed by 197
Abstract
Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by persistent difficulties in social interaction, communication, and repetitive behaviors. Neuroimaging studies have revealed structural and functional neural changes in individuals with ASD compared to healthy subjects. Objectives: This study aimed [...] Read more.
Background: Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by persistent difficulties in social interaction, communication, and repetitive behaviors. Neuroimaging studies have revealed structural and functional neural changes in individuals with ASD compared to healthy subjects. Objectives: This study aimed to investigate brain network structural connectivity in ASD using Morphometric Similarity Network (MSN) analysis. Methods: Data from the Autism Brain Imaging Data Exchange (ABIDE) were analyzed, comprising 597 individuals with ASD and 644 healthy controls. Structural connectivity was assessed using cortical morphometric features. Global and regional network indices, including the density index, node degree, node strength, and clustering coefficients, were evaluated. Results: Among the global network indices, when using a threshold value of 0.4, ASD patients compared to HCs showed a lower density (p = 0.041) and higher negative clustering (p = 0.0051) coefficients. For regional network indices, ASD patients showed a lower bilateral superior frontal cortices degree (left hemisphere: p = 0.014; right hemisphere: p = 0.0038) and strength (left: p = 0.017; right: p = 0.018). Additionally, they showed higher negative clustering coefficients in the bilateral superior frontal cortices (left, p = 0.0088; right, p = 0.0056) and bilateral pars orbitalis (left, p = 0.016; right, p = 0.0006), as well as lower positive clustering in the bilateral frontal pole (left, p = 0.03; right, p = 0.044). Conclusions: These findings highlight significant alterations in both global and regional brain network organization in ASD, which may contribute to the disorder’s cognitive and behavioral manifestations. Future studies are needed to investigate the pathophysiological mechanisms underlying these structural connectivity changes, to inform the development of more targeted and individualized therapeutic interventions for individuals with ASD. Full article
(This article belongs to the Special Issue Multimodal Imaging in Brain Development)
Show Figures

Figure 1

Figure 1
<p>Boxplots representing statistically significant between-groups differences in global and regional brain network indices. Legend: ASDpts = ASD patients; C<sub>i</sub><sup>−</sup> = negative clustering coefficient; C<sub>i</sub><sup>+</sup> = positive clustering coefficient; D = density index; D<sub>i</sub> = node degree; HCs = healthy controls; SFC = superior frontal cortex; Sn<sub>i</sub> = node strength.</p>
Full article ">
16 pages, 1308 KiB  
Article
The Dark Side of the Moon: A Good Adoption Rate Conceals the Unsolved Ethical Problem of Never-Adopted Dogs
by Sara Corsetti, Eugenia Natoli and Livia Malandrucco
Animals 2025, 15(5), 670; https://doi.org/10.3390/ani15050670 - 25 Feb 2025
Viewed by 244
Abstract
The no-kill policy for domestic dogs, adopted in Italy in 1991, reflects a growing interest in animal welfare and increases the chances of dogs being adopted and living with a family. However, unadoptable dogs must spend their entire lives in shelters. This paper [...] Read more.
The no-kill policy for domestic dogs, adopted in Italy in 1991, reflects a growing interest in animal welfare and increases the chances of dogs being adopted and living with a family. However, unadoptable dogs must spend their entire lives in shelters. This paper reports the adoption numbers from the ‘Muratella’ shelter (Rome) during the periods 2012–2016 (first period) and 2018–2022 (second period), illustrating the outcomes of the no-kill policy in a large metropolitan area. Furthermore, it discusses the ethical implications after 34 years of implementing Italian laws on the management of free-ranging dogs. During the first period, 7888 dogs entered the shelter, of which 4247 (53.84%) were adopted and 307 (3.89%) were not adopted. Similarly, during the second period, 8853 dogs entered the shelter, of which 4251 (49.11%) were adopted and 278 (3.16%) remained in the shelter by the end of 2022. Furthermore, we report the fate of unadopted dogs by the end of 2024. Despite the success in adoptions, the small percentage of dogs condemned to lifelong shelter residence still represents a significant number and warrants ethical reflection. Full article
(This article belongs to the Section Human-Animal Interactions, Animal Behaviour and Emotion)
Show Figures

Figure 1

Figure 1
<p>Fates of dogs entering the ‘Muratella’ shelter during the first period (<b>a</b>) and during the second period (<b>b</b>), along with their respective percentages: redeemed, adopted, still in the shelter, transferred, deceased (including natural causes and euthanasia), or returned to the territory.</p>
Full article ">Figure 2
<p>Cumulative permanence for dogs in the shelter ‘Muratella’ in Rome in the first period: (<b>a</b>) females (in pink) compared to males (in blue); (<b>b</b>) mixed-breed dogs (in green) compared to pure-breed derived dogs (in red); (<b>c</b>) puppies (size undetermined) (in light blue) compared to small (in purple), medium (in light green), and large (in red) size dogs; and (<b>d</b>) 0–2 months years old (in red) compared to 3–4 months (in azure), 5–7 months (in dark purple), 8–12 months (in light green), 1–2 years (in light blue), 3–5 years (in lilac), 6–7 years (in dark green), 8–10 years (in pink), 11–14 years (in dark blue), and 15–20 years old (in purple) dogs. A vertical drop in the curves indicates an event of adoption.</p>
Full article ">Figure 3
<p>Cumulative permanence for dogs in the shelter ‘Muratella’ in Rome in the second period: (<b>a</b>) females (in pink) compared to males (in blue); (<b>b</b>) mixed-breed dogs (in green) compared to pure-breed derived dogs (in red); (<b>c</b>) puppies (size undetermined) (in light blue) compared to small (in purple), medium (in light green), and large (in red) size dogs; and (<b>d</b>) 0–2 months years old (in red) compared to 3–4 months (in azure), 5–7 months (in dark purple), 8–12 months (in light green), 1–2 years (in light blue), 3–5 years (in lilac), 6–7 years (in dark green), 8–10 years (in pink), 11–14 years (in dark blue), and 15–20 years old (in purple) dogs. A vertical drop in the curves indicates an event of adoption.</p>
Full article ">
Back to TopTop